Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers May 21, 2018
Pharmacy Choice - News - Over-the-Counter Drugs - May 21, 2018

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 33     Next >>     Go To Page:

5/21/18 - Acerus to Report First Quarter 2018 Financial Results and Host Investor Call
By a News Reporter-Staff News Editor at Pharma Business Week Acerus Pharmaceuticals Corporation will announce its first quarter 2018 financial and operating results on Tuesday May 15, 2018 before market opens. The Company commercializes its products via its own salesforce in Canada, and through a global network of licensed distributors in the U.S
5/21/18 - Clean out the medicine cabinet
Spring cleaning takes on an entirely new meaning when getting ride of expired or unsafe medicines. The U.S. Food and Drug Administration says the medicine expiration date is critical when determining if a product is safe to use and will work as intended. Furthermore, keeping too many medications in a home particularly pain prescriptions can l
5/18/18 - Gene Delivery System Market to Expand at a CAGR of over 7.8% from 2017 to 2025: Global Gene Delivery System Market to Surpass US$ 4,281.0 Mn by 2025; Rising Incidence of Chronic Diseases and Technological Advancement to Fuel the Market: Transparency
Albany, NY 05/18/2018 Transparency Market Research has published a new report titled "Gene Delivery System Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017 2025". Key players introduce advanced technologies for drug delivery systems in North America and Europe; therefore, these regions are likely to accou
5/18/18 - Innovus Pharma to Exhibit Its FlutiCare and AllerVarx? Products at the American Thoracic Society Event in San Diego from Sunday, May 20, 2018 to Tuesday, May 22, 2018
Innovus Pharmaceuticals, Inc., an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men s and women's health and respiratory diseases, today announced that Robert Verfurth, the Company s Vice President, Sales and Marketing, will exhibit
5/18/18 - OPKO Plans to Address Draft Local Coverage Determination Published by Novitas Solutions for 4Kscore Test
OPKO Health, Inc. today announced that Novitas Solutions, Inc. issued a draft local coverage determination for the 4 Kscore test . Results of five new studies covering the 4 Kscore test will be presented at the American Urological Association's 2018 Annual Meeting this weekend in San Francisco, including the second study demonstrating the 4 Ksc
5/18/18 - Perrigo Confirms First To File Patent Challenge for Generic Version of Ultravate Lotion, 0.05%
DUBLIN- Perrigo Company plc today announced that Sun Pharmaceutical Industries, Inc. and MiCal Pharmaceuticals LLC initiated patent litigations on May 9 and 10, 2018, in the U.S.. District Court for the District of Delawareand in the U.S. District Court for the Western District of Michigan regarding Perrigo' s Paragraph IV Abbreviated New Drug Appl
5/18/18 - Reza Band Now Available Over the Counter for Relief of Chronic Acid Reflux Symptoms
By a News Reporter-Staff News Editor at Drug Week Somna Therapeutics LLC announced that the U.S. Food and Drug Administration has cleared the Reza Band as the first over-the-counter device of its kind for the reduction or elimination of laryngopharyngeal reflux symptoms. "The Reza Band has helped thousands of reflux sufferers finally find relief
5/17/18 - Acerus Announces Buyout of All Obligations under the Mattern License Agreement
Acerus Pharmaceuticals Corporation today reported that it has entered into an agreement with Mattern Pharma AG to buy out all of its obligations under the Amended and Restated Intellectual Property Rights and Product Development Agreement, dated December 21, 2013, including all of its future royalty payment obligations. $75 million or greater or U.
5/17/18 - FDA Approves First Non-Opioid Treatment for Management of Opioid Withdrawal Symptoms in Adults
The U.S. Department of Health and Human Services' Food and Drug Administration issued the following news release:. The U.S. Food and Drug Administration today approved Lucemyra for the mitigation of withdrawal symptoms to facilitate abrupt discontinuation of opioids in adults. The FDA will continue to encourage the innovation and development of the
5/17/18 - GNC Receives Stockholder Approval For Share Issuance In Connection With Hayao Investment
GNC Holdings, Inc. today announced that its stockholders approved the Company's proposal to issue convertible preferred shares to Harbin Pharmaceutical Group Holdings Co., Ltd. in connection with Hayao's $300 million strategic investment in the Company at the Company's Special Meeting of Stockholders, which reconvened on May 17, 2018.
5/17/18 - Innovus Pharma Announces the Launch of its Product Vesele in Canada
Innovus Pharmaceuticals, Inc., an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men s and women's health and respiratory diseases, today announced the launch of its product Vesele , approved by Health Canada for the increase in...
5/17/18 - Tapentadol Market: North America Is the Leading Market for Tapentadol: Tapentadol is often used to ease pain which cannot be managed with other types of analgesics. Its formulation is provided in 100 mg (red/orange), 75 mg (orange) and 50 mg (yellow)
San Francisco, CA 05/17/2018 The growing prevalence of chronic diseases is leading to the high occurrence of chronic musculoskeletal pain, which is likely to create an upswing in the demand for tapentadol worldwide. Tapentadol is also used for the treatment of moderate to severe acute pain. The potency of this treatment lies somewhere between
5/16/18 - AbbVie to Show Progress and Growth in Oncology Research at the American Society of Clinical Oncology 2018 Annual Meeting
AbbVie, a research-based global biopharmaceutical company, today announced it will present data about the company's portfolio of investigational oncology medicines during the American Society of Clinical Oncology Annual Meeting, June 1-5, in Chicago. Researchers will present data across multiple hematologic malignancies evaluating venetoclax, a..
5/16/18 - Dupixent (dupilumab) showed positive Phase 3 results in adolescents with inadequately controlled moderate-to-severe atopic dermatitis
PARIS and TARRYTOWN, N.Y., May 16, 2018/ PRNewswire/ A pivotal Phase 3 trial evaluating Dupixent to treat moderate-to-severe atopic dermatitis in adolescents met its primary and key secondary endpoints. 24% of patients who received weight-based dosing of Dupixent every two weeks and 18% of patients who received a fixed dose of Dupixent every f
5/16/18 - Follow-up Phase III Data Showed Genentech's Alecensa Helped People With ALK-Positive Metastatic Non-Small Cell Lung Cancer Live a Median of Almost Three Years Without Their Disease Worsening or Death
Genentech, a member of the Roche Group, today announced follow-up data from the Phase III ALEX study, showing that as an initial treatment Alecensa significantly reduced the risk of disease progression or death by 57 percent compared to crizotinib after two years of follow-up in people with anaplastic lymphoma kinase- positive metastatic non-sma
5/16/18 - Janssen to Present New Data in Urothelial, Hematologic and Prostate Cancers at ASCO 2018, Including Best of ASCO Selections
The Janssen Pharmaceutical Companies of Johnson& Johnson today announced 21 company-sponsored abstracts will be presented at the 2018 American Society of Clinical Oncology Annual Meeting in Chicago, IL on June 1-5. D., Global Therapeutic Area Head, Oncology, Janssen Research& Development, LLC. "In addition, new data for erdafitinib, a promising
5/16/18 - Pfizer's Biosimilar RETACRIT (epoetin Alfa-epbx) Approved by U.S. FDA
Pfizer, a pharmaceutical company, issued the following news release:. Pfizer Inc. today announced the United States Food and Drug Administration approved RETACRIT, a biosimilar to Epogen and Procrit 1, for all indications of the reference product. The FDA approval was based on a comprehensive data package submitted by Pfizer demonstrating a high de
5/16/18 - Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) Aims for Rapid Delivery of Cancer, Skin, Female Sexual Dysfunction Therapies
Pivot Pharmaceuticals Inc. is one of those companies, using the path to retail enabled by the Natural and Non-prescription Health Products Directorate in its effort to provide consumers with topical treatments for women s sexual dysfunction and psoriasis, and an oral product for cancer supportive care, while, in the United States, its cannabinoi
5/16/18 - Positive Phase 3 Trial of DUPIXENT (dupilumab) in Adolescents with Inadequately Controlled Moderate-to-severe Atopic Dermatitis
U.S. regulatory submission for patients ages 12-17 planned for third quarter 2018. Regeneron Pharmaceuticals, Inc. and Sanofi today announced that a pivotal Phase 3 trial evaluating DUPIXENT to treat moderate-to-severe atopic dermatitis in adolescents met its primary and key secondary endpoints. 24% of patients who received weight-based dosing o
5/16/18 - Sen. Alexander Issues Statement at Committee Hearing on Drug Pricing
Lamar Alexander, R- Tennessee, chairman of the Senate Health, Education, Labor and Pensions Committee, issued the following floor statement at a committee hearing entitled "Examining Oversight Reports on the 340 B Drug Pricing Program":. "The Senate Committee on Health, Education, Labor and Pensions will please come to order. "The Administration
5/16/18 - Sunovion Announces Data Presentations Highlighting Broad Portfolio of Treatments for COPD at the American Thoracic Society International Conference 2018
Sunovion Pharmaceuticals Inc. will present eight posters featuring data from its robust portfolio of treatments for chronic obstructive pulmonary disease at the American Thoracic Society International Conference 2018, taking place May 18-23, 2018, in San Diego, California. Both therapies are approved in the U.S. for the twice-daily, long-term...
5/15/18 - EDITORIAL: Want to lower drug prices? Let Medicare negotiate. [Bangor Daily News, Maine]
May 15 The price of brand name drugs have increased nearly 300 percent since 2010. On the campaign trail, President Donald Trump said lowering drug prices would be a priority if he were elected. He said Medicare, the largest single purchaser of medications in the U.S., should be able to negotiate for lower drug prices.
5/15/18 - Federal Register Extracts
The public meeting will provide patients with an opportunity to present to FDA their perspectives on the impacts of chronic pain, views on treatment approaches for chronic pain, and challenges or barriers to accessing treatments. FDA is particularly interested in hearing from patients who experience chronic pain that is managed with analgesic...
5/15/18 - INTRICON CORP - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations
Headquartered in Arden Hills, Minnesota, IntriCon Corporation is an international company engaged in designing, developing, engineering, manufacturing and distributing body-worn devices. In addition to its operations in Minnesota, the Company has facilities in Illinois, Singapore, Indonesia,. The Company sold the cardiac diagnostic monitoring busin
5/15/18 - Pfizer's Biosimilar RETACRIT (epoetin alfa-epbx) Approved by U.S. FDA
Pfizer Inc. today announced the United States Food and Drug Administration approved RETACRIT , a biosimilar to Epogen and Procrit 1, for all indications of the reference product. As the first approved epoetin alfa biosimilar in the U.S., RETACRIT may provide patients and their physicians with increased access to a high-quality, lower-cos
Articles(s): 1 - 25 of 33     Next >>     Go To Page:


© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415